Can Bundled Payment Model Improve Breast Cancer Outcomes?

March 14th 2025

Oncologists Reflect on Pandemic's Lasting Impact on Cancer Care

Results from the CheckMate649 trial support the use of nivolumab plus chemotherapy in the treatment of advanced gastric cancers.

Aditya Bardia, MD, MPH;Ritu Salani, MD;Scarlett Lin Gomez, PhD;Marwan G. Fakih, MD;Elizabeth Ren Zhang-Velten, MD, PhD;Frances Chow, MD;James B. Yu, MD, MHS, FASTRO

March 10th 2025

Highlighting Developments and Informing Treatment Planning in CLL Care

Hear from leading cancer experts about the lasting impact the COVID-19 pandemic has left on clinical practice.

Clinical guidelines aimed at both clinicians and patients seek to educate and include both parties in clinical decision-making processes.

Roman Fabbricatore

Traversing the Complexities of Non-Clear Cell Renal Cell Carcinoma

Clinical guidelines aimed at both clinicians and patients seek to educate and include both parties in clinical decision-making processes.

Manojkumar Bupathi, MD, MS;Benjamin Garmezy, MD;Stephanie A. Berg, DO

March 7th 2025

New Cohort Approved in Phase 1/2 Trial of TTX-MC138 in Solid Cancers

A brief overview of the current RCC landscape was provided in the most recent Oncology Decoded podcast.

Tim Cortese

Five-Year Impact of the COVID-19 Pandemic on the Oncology Community

Based on positive safety data from the third cohort, a safety review committee approved the opening of a fourth cohort as well as more enrollment into the third cohort.

Updated Nivolumab Data Solidify Use in Advanced Gastric/GEJ/Esophageal Cancers

Leading multidisciplinary oncology professionals look back at how the COVID-19 pandemic changed cancer care.

Related Content

March 14th 2025

Oncologists Reflect on Pandemic's Lasting Impact on Cancer Care

Results from the CheckMate649 trial support the use of nivolumab plus chemotherapy in the treatment of advanced gastric cancers.

Aditya Bardia, MD, MPH;Ritu Salani, MD;Scarlett Lin Gomez, PhD;Marwan G. Fakih, MD;Elizabeth Ren Zhang-Velten, MD, PhD;Frances Chow, MD;James B. Yu, MD, MHS, FASTRO

March 10th 2025

Highlighting Developments and Informing Treatment Planning in CLL Care

Hear from leading cancer experts about the lasting impact the COVID-19 pandemic has left on clinical practice.

Roman Fabbricatore

Traversing the Complexities of Non-Clear Cell Renal Cell Carcinoma

Clinical guidelines aimed at both clinicians and patients seek to educate and include both parties in clinical decision-making processes.

Manojkumar Bupathi, MD, MS;Benjamin Garmezy, MD;Stephanie A. Berg, DO

March 7th 2025

New Cohort Approved in Phase 1/2 Trial of TTX-MC138 in Solid Cancers

A brief overview of the current RCC landscape was provided in the most recent Oncology Decoded podcast.

Tim Cortese

Five-Year Impact of the COVID-19 Pandemic on the Oncology Community

Based on positive safety data from the third cohort, a safety review committee approved the opening of a fourth cohort as well as more enrollment into the third cohort.